Latest News and Press Releases

Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, Belgium on March 19, 2025. COO Valerie Ceva will...

New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- The phrase 'emergency medical apparatus' encompasses a diverse range of tools and gadgets specifically designed for the purpose of...

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Tele-ICU Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering.The Global Tele-ICU Patent Landscape has showcased a...

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Tele-intensive Care Unit Market by Component, Type, End-user, and Region" report has been added to ResearchAndMarkets.com's offering. This...

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai, United Arab Emirates, a Gateway to the Middle East and Africa

CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.

CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024

CytoSorbents and Converge Biotech Partner In India to Expand CytoSorb Blood Purification Availability to Treat Sepsis and Other Deadly Conditions

Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is an immune system regulator that interrupts the...

CytoSorbents to Announce Q3 2024 Financial and Operating Results on November 7, 2024